Perspective Therapeutics, Inc. — Form 10-Q
Filed August 10, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 15/100
What the filing says
The filing is a standard Form 10-Q for the six months ended June 30, 2026, filed August 10, 2026. The document index shows 60 exhibits and standard certifications (31.1, 31.2, 32) but the actual financial statements, MD&A, and material developments are not excerpted in the provided text. No specific financial metrics, deal announcements, operational changes, or corporate events are disclosed in this extract.
Why this rating
Routine quarterly filing with no substantive detail provided. Cannot assess material changes without actual 10-Q content—statements, MD&A, or risk disclosures unavailable in submission text.
See more from August 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.